![Victor Li Lietao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Victor Li Lietao
Direttore/Membro del Consiglio presso BioSyngen Pte Ltd.
Posizioni attive di Victor Li Lietao
Società | Posizione | Inizio | Fine |
---|---|---|---|
BioSyngen Pte Ltd.
![]() BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Victor Li Lietao
Precedenti posizioni note di Victor Li Lietao
Società | Posizione | Inizio | Fine |
---|---|---|---|
Lion TCR Pte Ltd.
![]() Lion TCR Pte Ltd. BiotechnologyHealth Technology Lion TCR Pte Ltd. operates as a clinical-stage biotechnology company. The firm focuses on the development of T cell receptor (TCR)-T cell therapy against life-threatening viral infections and viral-related cancers pertinent in Asia. The company was founded by Li Lietao and Antonio Bertoletti and is headquartered in Singapore. | Amministratore Delegato | - | - |
Presidente | - | - | |
Fondatore | - | - |
Statistiche
Distribuzione geografica
Singapore | 3 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Lion TCR Pte Ltd.
![]() Lion TCR Pte Ltd. BiotechnologyHealth Technology Lion TCR Pte Ltd. operates as a clinical-stage biotechnology company. The firm focuses on the development of T cell receptor (TCR)-T cell therapy against life-threatening viral infections and viral-related cancers pertinent in Asia. The company was founded by Li Lietao and Antonio Bertoletti and is headquartered in Singapore. | Health Technology |
BioSyngen Pte Ltd.
![]() BioSyngen Pte Ltd. Pharmaceuticals: MajorHealth Technology BioSyngen Pte Ltd. focuses on the clinical and commercial transfer of immune-cell therapy technologies and products. The company was founded in 2016 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Victor Li Lietao
- Esperienza